These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21499229)

  • 41. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update.
    Hong JY; Ko YH; Kim SJ; Kim WS
    Curr Opin Oncol; 2015 Sep; 27(5):392-8. PubMed ID: 26258272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
    Okamoto A; Yanada M; Miura H; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
    Cancer Sci; 2015 Nov; 106(11):1576-81. PubMed ID: 26353084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr virus (EBV)-infected cells were frequently but dispersely detected in T-cell lymphomas of various types by in situ hybridization with an RNA probe specific to EBV-specific nuclear antigen 1.
    Yamamoto T; Nakamura Y; Kishimoto K; Takeuchi H; Shirakata M; Mitsuya T; Hirai K
    Virus Res; 1999 Dec; 65(1):43-55. PubMed ID: 10564752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
    Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
    Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.
    Quintanilla-Martinez L; Fend F; Moguel LR; Spilove L; Beaty MW; Kingma DW; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Oct; 23(10):1233-40. PubMed ID: 10524524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of EBV antigens detected by a sensitive method in pediatric and adult Diffuse Large B-cell lymphomas.
    Mangiaterra TS; De Dios Soler M; Oviedo N; Colli S; Preciado MV; Soria M; Galluzo L; De Matteo E; Chabay P
    Int J Cancer; 2023 Sep; 153(5):1043-1050. PubMed ID: 37318089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positivity and clinical course.
    De Bruin PC; Jiwa NM; Van der Valk P; Van Heerde P; Gordijn R; Ossenkoppele GJ; Walboomers JM; Meijer CJ
    Histopathology; 1993 Dec; 23(6):509-18. PubMed ID: 8314234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.
    Stuhlmann-Laeisz C; Borchert A; Quintanilla-Martinez L; Hoeller S; Tzankov A; Oschlies I; Kreuz M; Trappe R; Klapper W
    Leuk Lymphoma; 2016; 57(1):39-44. PubMed ID: 25899404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus (EBV) provides survival factors to EBV
    Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
    Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
    Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
    Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas.
    Herbst H; Dallenbach F; Hummel M; Niedobitek G; Finn T; Young LS; Rowe M; Müller-Lantzsch N; Stein H
    Blood; 1991 Nov; 78(10):2666-73. PubMed ID: 1668608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EBV-associated diffuse large B-cell lymphoma arising in the chest wall with surgical mesh implant.
    Fujimoto M; Haga H; Okamoto M; Obara E; Ishihara M; Mizuta N; Nishimura K; Manabe T
    Pathol Int; 2008 Oct; 58(10):668-71. PubMed ID: 18801089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype.
    Gibson SE; Hsi ED
    Hum Pathol; 2009 May; 40(5):653-61. PubMed ID: 19144386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
    Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
    Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types.
    Hummel M; Anagnostopoulos I; Korbjuhn P; Stein H
    J Pathol; 1995 Mar; 175(3):263-71. PubMed ID: 7745495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
    Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
    J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
    Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
    Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
    Jeon YK; Lee BY; Kim JE; Lee SS; Kim CW
    Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr virus frequency in primary central nervous system lymphomas in Turkey.
    Saglam A; Akyurek N; Soylemezoglu F; Uner A
    APMIS; 2013 Mar; 121(3):232-8. PubMed ID: 23030256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.